Search Results 241-250 of 7496 for albumin

  1. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

    Albumin > 3 mg/dl; Blood urea nitrogen (BUN) =< 30 mg/dl; Creatinine =< 1.7 mg/dl; The following imaging workup to document metastases within 45 days prior to ...

  2. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

    Albumin ≥3.0 g/dL; 8. Acceptable coagulation parameters including international normalized ratio (INR) <1.5 and partial thromboplastin time (PTT) ...

  3. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Serum albumin ≥ 2 g/dL; Blood glucose normal; Not pregnant or nursing; Negative pregnancy test; Fertile patients must use effective contraception during and ...

  4. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Serum albumin < 3.5 g/ dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

  5. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    - Serum albumin >= 30 g/L (3.0 g/dL) (obtained =< 28 days prior to randomization) - For subjects not receiving therapeutic anticoagulation: international ...

  6. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Serum albumin ≥ 2.8 g/dL. Lipase < 2.0 x ULN and no radiologic or clinical evidence of pancreatitis. Urine protein/creatinine ratio (UPCR) ≤ 1 mg/mg ...

  7. Biospecimens and Clinical Database Core - Mayo Clinic Comprehensive Cancer Center Research

    The Biospecimens and Clinical Database Core in the Mayo Clinic Multiple Myeloma SPORE coordinates sample collection, processing and tracking for research.

  8. A Study to Evaluate Pevonedistat, Azacitidine (or Decitabine), and Venetoclax (PAVE) to Treat Acute Myelogenous Leukemia (AML) Patients - Mayo Clinic

    Albumin > 2.7 g/dL; · Total bilirubin ≤ institutional upper limit of normal (ULN). · Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ...

  9. Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations - Mayo Clinic

    - Albumin levels < 2.5 g/dl - Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects ...

  10. Multiple sclerosis - Symptoms and causes - Mayo Clinic

    Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS , the immune system attacks the ...